Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.35 (8.14%)
Bid:
4.65
Ask:
4.80
Spread: 0.15 (3.226%)
Market Cap: £40.44m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Full year results 2022

26 May 2023 07:00

RNS Number : 7326A
Revolution Beauty Group PLC
26 May 2023
 

For Immediate Release

26 May 2023

 

 

 

 

REVOLUTION BEAUTY GROUP PLC

("Revolution Beauty", the "Group" or the "Company")

 

Full year results 2022

Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator, today announces the publication of its audited full year results for the financial year ended 28 February 2022 ("FY22").

Revolution Beauty's full Annual Report and Accounts for FY22 has been published on the Company's website and can be accessed at the following address (https://revolutionbeautyplc.com/results-and-reports/). This, together with the publication of the interim results within the next two weeks, are important steps towards the lifting of the suspension of its shares.

The Board encourages Shareholders to read the Annual Report in its entirety and has not summarised the key elements in this release given the complexity of the matters considered and the connected adjustments and disclosures. The Annual Report sets out several adjustments in respect of issues and errors identified, some of which have been corrected by restating previous financial periods and others which have been corrected in FY22.

The Company intends to publish its interim results for the period ended 31 August 2022 within the next two weeks. This announcement will also contain an update on the FY23 financial year, current trading during FY24 to date and provide an update on progress towards the lifting of the suspension of trading in the Group's shares.

The Board draws shareholders attention to the form of the Audit Report on the Group financial statements issued by BDO LLP, which contains several important qualifications, including a material uncertainty around going concern. This arises due to potential non-financial breaches of lender covenants arising from the Company's current suspension of shares, and the likely carry forward of certain qualifications into the FY23 Audit Report. The Group continues to enjoy the support of its banking partners and expects this to continue. The Board also draws shareholders attention to the form of the separate Audit Report on the company financial statements.

The interim results announcement will also contain details of a capital markets event at which Bob Holt and Elizabeth Lake will outline Revolution Beauty's strategy, growth ambitions and plan to deliver the full potential of the Company. The date for the capital markets event will be announced in due course.

 

Derek Zissman, Non-Executive Chairman of Revolution Beauty, said:

"The delay in the publication of our FY2022 results has clearly been frustrating for all involved. Following the completion of the Independent Investigation and the release of its findings, we continue to take action to ensure we have the right processes and governance in place across our business. We are making significant progress to resolve the issues that were raised.

Whilst these results are significantly below that forecast by the previous management team to the market, they nevertheless reflect a robust business with a strong brand, loyal following, and significant potential in terms of both sales and profitability. We now expect Revolution Beauty to return to normalised trading and to capitalise on its position as a business with outstanding products, talented colleagues, and a loyal customer base."

 

Bob Holt, CEO of Revolution Beauty, said:

 

"Integrity and honesty in every aspect of our business is paramount. This has been the focus of the new leadership team as we reset internal controls and processes to ensure that we are in a position to achieve consistent operational excellence at a global scale, and in line with the standards of a UK plc.

 

"Revolution Beauty is a much-loved brand with strong partner distribution networks, and I believe that we have the right strategy, people and customer offering to thrive in the long-term. The culture of the business continues to be based on providing affordable beauty around the world, and we are well positioned in the current environment, to continue to adapt and respond to changing consumer trends.

 

"I would like to thank all of our Revolution teams around the world for their significant commitment to our business as we work hard to deliver its full potential within the growing beauty market.

 

"We are focused on delivering sustainable growth for all our stakeholders, and the current financial year - FY24 - has started positively. We are confident as we look ahead."

 

For further information please contact:

Revolution Beauty Investor Relations

Bob Holt / Elizabeth Lake

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

 

 

Zeus (NOMAD): Nick Cowles /Jamie Peel /Jordan Warburton

 

Tel: +44 (0) 161 831 1512

Liberum: Clayton Bush / Edward Thomas / Miquela Bezuidenhoudt

 

Tel: +44 (0) 203 100 2222

Media enquiries:

Headland Consultancy

Rosh Field / Will Smith

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSEEFWIEDSEII
Date   Source Headline
5th Jun 20267:00 amRNSFinancial Conduct Authority Update
16th Apr 20267:00 amRNSGrant of Share Options
1st Apr 202611:35 amRNSTotal Voting Rights
11th Mar 20267:00 amRNSAppointment of Nominated Adviser
2nd Mar 202611:28 amRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jan 20263:48 pmRNSTotal Voting Rights
15th Dec 20256:18 pmRNSDirector/PDMR Shareholding
1st Dec 20255:43 pmRNSTotal Voting Rights
27th Nov 20253:59 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSInterim Results
26th Nov 20256:15 pmRNSRelated Party Transaction
4th Nov 20254:32 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTotal Voting Rights
30th Sep 20259:33 amRNSResult of AGM
24th Sep 20257:00 amRNSDirectorate Change
18th Sep 20257:00 amRNSHolding(s) in Company
17th Sep 202512:30 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSDirector/PDMR Shareholding
16th Sep 20255:17 pmRNSHolding(s) in Company
16th Sep 20259:11 amRNSHolding(s) in Company
11th Sep 20254:09 pmRNSResults of General Meeting
2nd Sep 20258:30 amRNSTotal Voting Rights
1st Sep 20255:06 pmRNSHolding(s) in Company
1st Sep 20258:33 amRNSHolding(s) in Company
29th Aug 20254:50 pmRNSFinal Results, Annual Report Posting & AGM Notice
26th Aug 20257:01 amRNSCircular Publication, Notice of GM & Board Update
26th Aug 20257:00 amRNSResult of Retail Offer to existing shareholders
22nd Aug 20254:31 pmRNSPDMR Dealing
22nd Aug 20253:30 pmRNSHolding(s) in Company
22nd Aug 20258:52 amRNSHolding(s) in Company
22nd Aug 20258:40 amRNSRetail Offer to existing shareholders
22nd Aug 20258:09 amRNSResult of Placing and Subscription
22nd Aug 20257:02 amRNSProposed Placing and Subscription via ABB
22nd Aug 20257:01 amRNSPreliminary Unaudited Results
22nd Aug 20257:00 amRNSTermination of Formal Sale Process
21st Aug 202510:51 amRNSForm 8.5 (EPT/RI)
20th Aug 202510:28 amRNSForm 8.5 (EPT/RI)
19th Aug 202512:27 pmRNSFY25 Trading Update
19th Aug 202510:01 amRNSForm 8.5 (EPT/RI)
18th Aug 202510:27 amRNSForm 8.5 (EPT/RI)
15th Aug 20254:11 pmRNSHolding(s) in Company
15th Aug 20259:57 amRNSForm 8.5 (EPT/RI)
14th Aug 202510:25 amRNSForm 8.5 (EPT/RI)
13th Aug 202510:31 amRNSForm 8.5 (EPT/RI)
12th Aug 202510:05 amRNSForm 8.5 (EPT/RI)
11th Aug 202510:26 amRNSForm 8.5 (EPT/RI)
8th Aug 202511:31 amRNSForm 8.5 (EPT/RI)
7th Aug 20254:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.